Search
TD101
go.drugbank.com/drugs/DB06596InvestigationalTD101, a small interfering RNA (siRNA) designed for the treatment of pachyonychia congenita
ZYCOV-D
go.drugbank.com/drugs/DB15892ExperimentalAs of August, 2020 the candidate is in Phase II clinical trials[A219758]. … Once the plasmid DNA is introduced into host cells and the viral protein is translated, it elicits a strong immune response, stimulating the humoral and cellular components of the immune system[L16503]
CM583
go.drugbank.com/drugs/DB33976ExperimentalCM583 is a small molecule drug. CM583 is under investigation in clinical trial NCT07823764 (Study of CM583 in Healthy Participants).
Timbetasin
go.drugbank.com/drugs/DB19119InvestigationalTimbetasin is under investigation in clinical trial NCT05555589 (Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2).
Zotiraciclib
go.drugbank.com/drugs/DB16656InvestigationalZotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide … Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).